Skip to content
  • Sponsors
  • Sponsorship Opportunities
  • The Connecticut Health I-Team
  • Contact
Donate Now
  • Donate Now
  • C-HIT
  • C-HIT
  • Veterans’ Health
  • Environmental Health
  • Women’s Health
  • Disparities
  • Fines & Sanctions
  • Donate Now
  • Global Navigation
    • Sponsors
    • Sponsorship Opportunities
    • The Connecticut Health I-Team
    • Contact

Connecticut Health Investigative Team - In-depth Journalism on Issues of Health and Safety

Connecticut Health Investigative Team (http://c-hit.org/tag/ronald-duman/)

  • Veterans’ Health
  • Environmental Health
  • Women’s Health
  • Disparities
  • Fines & Sanctions
  • I-Team In-Depth
  • News Ticker
  • Data Mine
  • Health Reform Watch
  • Students’ Work
  • Events
  • Podcast
  • Health Q&A
Subscribe

Ronald Duman

Chronic Depression

After SSRIs: Yale Scientists Map New Pathway To Treat Depression

By Lisa Chedekel | October 4, 2012

For a decade, scientists have been trying to explain why a single dose of the drug ketamine manages to do what typical antidepressants don’t: Lift symptoms of chronic depression within hours, rather than weeks, in treatment-resistant patients.

  • Connecticut Health I-Team
  • The Connecticut Health I-Team
  • Sponsors
  • Contributors
  • Contact

In Case You Missed It

  • Low-Income Children Are Most Vulnerable To Pandemic’s Long-Term Effects

    Tameeka Coleman and six of her children lived on the streets before moving into a shelter in Fairfield.

  • Pandemic Exposes Stark Health Disparities Generations In The Making

    Soon after Minerva Cuapio, a 48-year-old Mexican immigrant who lives in New Haven, was laid off from her job at a dry cleaner in March, she developed a headache, an itchy throat and a dry cough.

Follow Us

Like Us on FacebookFollow Us on TwitterSubscribe via RSS

© Copyright 2021, Connecticut Health I-Team

  • Site Policies

Built with the Largo WordPress Theme from the Institute for Nonprofit News.

Back to top ↑